Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of selective kinase inhibitors. Its structure supports binding to specific enzyme targets involved in inflammatory and oncological pathways. Commonly utilized in research settings for designing drugs with improved metabolic stability and target specificity. Also employed in the preparation of analogs for structure-activity relationship (SAR) studies due to its rigid cyclobutane core and halogenated aromatic group, which enhance molecular diversity and pharmacokinetic properties.